Global Rapid Pathogen Detection Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Rapid Pathogen Detection Market Insights, Forecast to 2034
Rapid pathogen detection refers to the timely and accurate identification of pathogens, such as bacteria, viruses, or other microorganisms, in various samples. The objective is to quickly determine the presence of pathogens and take appropriate actions to prevent their spread, implement necessary control measures, and ensure public health and safety.
Market Analysis and InsightsGlobal Rapid Pathogen Detection Market
Global Rapid Pathogen Detection market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Rapid Pathogen Detection industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
The market for rapid pathogen detection is growing rapidly due to the market growth is driven by factors such as the increasing incidence of infectious diseases, growing food safety concerns, rising demand for advanced diagnostic technologies, and the need for rapid and accurate detection of pathogens for effective disease management. North America holds a significant market share in the rapid pathogen detection market, followed by Europe and the Asia Pacific region. The market growth in these regions is driven by factors such as the presence of major market players, increasing investments in healthcare infrastructure, stringent regulations for food safety, and the rising prevalence of infectious diseases.
Report Covers
This report presents an overview of global Rapid Pathogen Detection market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Rapid Pathogen Detection market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
Bureau Veritas
SGS SA
Intertek Group
Eurofins Scientific
Bio-Rad Laboratories
QIAGEN
ALS
Merieux NutriSciences
Microbac Laboratories
AsureQuality
Campden BRI
Charles River
Segment by Type
Enzyme-Linked Immunosorbent Assays
Immunochromatographic Assays
Fluorescent Immunoassays
Food Safety
Clinical Research
Drug Discovery
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Rapid Pathogen Detection introduction, etc. Rapid Pathogen Detection Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Rapid Pathogen Detection
Chapter 13Methodology and Data Sources adopted by MRAResearch
Market Analysis and InsightsGlobal Rapid Pathogen Detection Market
Global Rapid Pathogen Detection market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Rapid Pathogen Detection industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
The market for rapid pathogen detection is growing rapidly due to the market growth is driven by factors such as the increasing incidence of infectious diseases, growing food safety concerns, rising demand for advanced diagnostic technologies, and the need for rapid and accurate detection of pathogens for effective disease management. North America holds a significant market share in the rapid pathogen detection market, followed by Europe and the Asia Pacific region. The market growth in these regions is driven by factors such as the presence of major market players, increasing investments in healthcare infrastructure, stringent regulations for food safety, and the rising prevalence of infectious diseases.
Report Covers
This report presents an overview of global Rapid Pathogen Detection market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Rapid Pathogen Detection market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
Bureau Veritas
SGS SA
Intertek Group
Eurofins Scientific
Bio-Rad Laboratories
QIAGEN
ALS
Merieux NutriSciences
Microbac Laboratories
AsureQuality
Campden BRI
Charles River
Segment by Type
Enzyme-Linked Immunosorbent Assays
Immunochromatographic Assays
Fluorescent Immunoassays
Segment by Application
Food Safety
Clinical Research
Drug Discovery
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Rapid Pathogen Detection introduction, etc. Rapid Pathogen Detection Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Rapid Pathogen Detection
Chapter 13Methodology and Data Sources adopted by MRAResearch